Spech H J, Liehr H
Z Gastroenterol. 1982 Jul;20(7):393-404.
Alpha 1-antitrypsin (alpha 1 AT) is a glycoprotein of hepatic origin which functions as a systemic protease inhibitor (Pi). Its production is controlled by two autosomal-codominantly transmitted alleles. Among the numerous genetic variants some alleles (predominantly PiZ) may induce alpha 1 AT-deficiency, facultatively associated with childhood liver disease. However, the pathogenesis of this congenital disorder, which may progress to complete cirrhosis remains obscure at present. In addition, no clear cut relationship has been proven between alpha 1 AT-deficiency and deranged liver architecture, observed in advanced aged adults. Possibly this may reflect a more accidental coincidence with the consequences of chronic viral hepatitis (Non A-Non B-type). Nevertheless, this hypothesis is hitherto unestablished as it holds for the supposed association between alpha 1 AT-deficiency and the occurrence of malignant hepatoma.
α1-抗胰蛋白酶(α1AT)是一种源自肝脏的糖蛋白,其功能是作为一种全身性蛋白酶抑制剂(Pi)。它的产生由两个常染色体共显性传递的等位基因控制。在众多遗传变异中,一些等位基因(主要是PiZ)可能会导致α1AT缺乏,这种缺乏可能与儿童期肝病相关。然而,这种先天性疾病的发病机制目前仍不清楚,它可能会发展为完全肝硬化。此外,在老年人中观察到的α1AT缺乏与肝脏结构紊乱之间尚未证实存在明确的关系。这可能更多地反映了与慢性病毒性肝炎(非甲非乙型)后果的偶然巧合。然而,这一假设迄今尚未确立,因为它适用于α1AT缺乏与恶性肝癌发生之间的假定关联。